Abstract
Studies using animal models of hypercholesterolemia have established that taurine reduces cholesterol levels; however, the precise mechanism underlying this cholesterol-lowering effect is unclear. This study addressed this issue by investigating whether bile acid/farnesoid X receptor (FXR) signaling is involved in taurine-mediated cholesterol-lowering effect. Fxr-null and wild-type mice were administered 2% (w/v) taurine in their drinking water and fed a control diet or control diet supplemented with 1% (w/w) cholesterol (cholesterol diet) for 10 days. Taurine intake did not significantly alter hepatic and serum total cholesterol (TC) levels and bile acid compositions of the liver and intestinal lumen in Fxr-null and wild-type mice fed the control diet. By changing to a cholesterol diet, taurine intake significantly decreased hepatic and serum cholesterol levels in wild-type mice. In contrast, it significantly decreased hepatic, not serum, cholesterol levels in Fxr-null mice. Taurine intake significantly altered the bile acid composition of the intestinal lumen in wild-type mice fed a cholesterol diet, but not in Fxr-null mice. An increase in FXR antagonistic bile acids was detected in the intestinal lumen of taurine-treated wild-type mice fed a cholesterol diet. Taurine intake reduced the ileal expression of FXR target genes fibroblast growth factor 15 (Fgf15) and small heterodimer partner (Shp). In contrast, it enhanced the hepatic expression of cholesterol 7α-hydroxylase (Cyp7a1) in wild-type mice fed a cholesterol diet, but not in Fxr-null mice. These results suggest that taurine is partially involved in cholesterol lowering by reducing the ileal FXR signaling due to the alteration of ileal bile acid composition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cariou B, Staels B (2007) FXR: a promising target for the metabolic syndrome? Trends Pharmacol Sci 28(5):236–243. https://doi.org/10.1016/j.tips.2007.03.002
Chang YY, Chou CH, Chiu CH, Yang KT, Lin YL, Weng WL, Chen YC (2011) Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol dietary habit. J Agric Food Chem 59(1):450–457. https://doi.org/10.1021/jf103167u
Chen W, Nishimura N, Oda H, Yokogoshi H (2003) Effect of taurine on cholesterol degradation and bile acid pool in rats fed a high-cholesterol diet. Adv Exp Med Biol 526:261–267. https://doi.org/10.1007/978-1-4615-0077-3_33
Chen W, Suruga K, Nishimura N, Gouda T, Lam VN, Yokogoshi H (2005) Comparative regulation of major enzymes in the bile acid biosynthesis pathway by cholesterol, cholate and taurine in mice and rats. Life Sci 77(7):746–757. https://doi.org/10.1016/j.lfs.2004.11.036
Chen W, Guo JX, Chang P (2012) The effect of taurine on cholesterol metabolism. Mol Nutr Food Res 56(5):681–690. https://doi.org/10.1002/mnfr.201100799
Chen W, Guo J, Zhang Y, Zhang J (2016) The beneficial effects of taurine in preventing metabolic syndrome. Food Funct 7(4):1849–1863. https://doi.org/10.1039/c5fo01295c
Chiang JY (2009) Bile acids: regulation of synthesis. J Lipid Res 50(10):1955–1966. https://doi.org/10.1194/jlr.R900010-JLR200
Chiang JYL, Ferrell JM (2019) Bile acids as metabolic regulators and nutrient sensors. Annu Rev Nutr 39:175–200. https://doi.org/10.1146/annurev-nutr-082018-124344
Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226(1):497–509
Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6(3):517–526. https://doi.org/10.1016/s1097-2765(00)00051-4
Guo J, Gao Y, Cao X, Zhang J, Chen W (2017) Cholesterol-lowing effect of taurine in HepG2 cell. Lipids Health Dis 16(1):56. https://doi.org/10.1186/s12944-017-0444-3
Hasegawa S, Uenoyama R, Takeda F, Chuma J, Baba S, Kamiyama F, Iwakawa M, Fushimi M (1983) A highly sensitive determination of individual serum bile acids using high-performance liquid chromatography with immobilized enzyme. J Chromatogr 278(1):25–34. https://doi.org/10.1016/s0378-4347(00)84752-0
Hoang MH, Jia Y, Jun HJ, Lee JH, Hwang KY, Choi DW, Um SJ, Lee BY, You SG, Lee SJ (2012) Taurine is a liver X receptor-alpha ligand and activates transcription of key genes in the reverse cholesterol transport without inducing hepatic lipogenesis. Mol Nutr Food Res 56(6):900–911. https://doi.org/10.1002/mnfr.201100611
Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, Donahee M, Wang DY, Mansfield TA, Kliewer SA, Goodwin B, Jones SA (2003) Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17(13):1581–1591. https://doi.org/10.1101/gad.1083503
Huang F, Zheng X, Ma X, Jiang R, Zhou W, Zhou S, Zhang Y, Lei S, Wang S, Kuang J, Han X, Wei M, You Y, Li M, Li Y, Liang D, Liu J, Chen T, Yan C, Wei R, Rajani C, Shen C, Xie G, Bian Z, Li H, Zhao A, Jia W (2019) Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. Nat Commun 10(1):4971. https://doi.org/10.1038/s41467-019-12896-x
Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72(1):101–163. https://doi.org/10.1152/physrev.1992.72.1.101
Imae M, Asano T, Murakami S (2014) Potential role of taurine in the prevention of diabetes and metabolic syndrome. Amino Acids 46(1):81–88. https://doi.org/10.1007/s00726-012-1434-4
Jiang C, Xie C, Lv Y, Li J, Krausz KW, Shi J, Brocker CN, Desai D, Amin SG, Bisson WH, Liu Y, Gavrilova O, Patterson AD, Gonzalez FJ (2015) Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat Commun 6:10166. https://doi.org/10.1038/ncomms10166
Kitada H, Miyata M, Nakamura T, Tozawa A, Honma W, Shimada M, Nagata K, Sinal CJ, Guo GL, Gonzalez FJ, Yamazoe Y (2003) Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. J Biol Chem 278(20):17838–17844. https://doi.org/10.1074/jbc.M210634200
Kliewer SA, Mangelsdorf DJ (2015) Bile acids as hormones: the FXR-FGF15/19 pathway. Dig Dis 33(3):327–331. https://doi.org/10.1159/000371670
Kuribayashi H, Miyata M, Yamakawa H, Yoshinari K, Yamazoe Y (2012) Enterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling. Eur J Pharmacol 697(1–3):132–138. https://doi.org/10.1016/j.ejphar.2012.09.048
Lam NV, Chen W, Suruga K, Nishimura N, Goda T, Yokogoshi H (2006) Enhancing effect of taurine on CYP7A1 mRNA expression in Hep G2 cells. Amino Acids 30(1):43–48. https://doi.org/10.1007/s00726-005-0244-3
Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, Fabre KM, Mitchell JB, Patterson AD, Gonzalez FJ (2013) Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun 4:2384. https://doi.org/10.1038/ncomms3384
Matsubara T, Li F, Gonzalez FJ (2013) FXR signaling in the enterohepatic system. Mol Cell Endocrinol 368(1–2):17–29. https://doi.org/10.1016/j.mce.2012.05.004
Militante JD, Lombardini JB (2002) Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids 23(4):381–393. https://doi.org/10.1007/s00726-002-0212-0
Miyata M, Takamatsu Y, Kuribayashi H, Yamazoe Y (2009) Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression. J Pharmacol Exp Ther 331(3):1079–1085. https://doi.org/10.1124/jpet.109.160093
Miyata M, Funaki A, Fukuhara C, Sumiya Y, Sugiura Y (2020) Taurine attenuates hepatic steatosis in a genetic model of fatty liver disease. J Toxicol Sci 45(2):87–94. https://doi.org/10.2131/jts.45.87
Murakami S, Kondo-Ohta Y, Tomisawa K (1999) Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci 64(1):83–91. https://doi.org/10.1016/s0024-3205(98)00536-0
Murakami S, Kondo Y, Toda Y, Kitajima H, Kameo K, Sakono M, Fukuda N (2002) Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70(20):2355–2366. https://doi.org/10.1016/s0024-3205(02)01507-2
Murakami S, Fujita M, Nakamura M, Sakono M, Nishizono S, Sato M, Imaizumi K, Mori M, Fukuda N (2016) Taurine ameliorates cholesterol metabolism by stimulating bile acid production in high-cholesterol-fed rats. Clin Exp Pharmacol Physiol 43(3):372–378. https://doi.org/10.1111/1440-1681.12534
Neimark E, Chen F, Li X, Shneider BL (2004) Bile acid-induced negative feedback regulation of the human ileal bile acid transporter. Hepatology 40(1):149–156. https://doi.org/10.1002/hep.20295
Nguyen JT, Riessen RR, Zhang T, Kieffer C, Anakk S (2021) Deletion of intestinal SHP impairs short-term response to cholic acid challenge in male mice. Endocrinology. https://doi.org/10.1210/endocr/bqab063
Nishimura N, Yamamoto T, Ota T (2009) Taurine feeding inhibits bile acid absorption from the ileum in rats fed a high cholesterol and high fat diet. Adv Exp Med Biol 643:285–291. https://doi.org/10.1007/978-0-387-75681-3_29
Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T, Oresic M, Backhed F (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17(2):225–235. https://doi.org/10.1016/j.cmet.2013.01.003
Shin DJ, Osborne TF (2009) FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action. J Biol Chem 284(17):11110–11120. https://doi.org/10.1074/jbc.M808747200
Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102(6):731–744. https://doi.org/10.1016/s0092-8674(00)00062-3
Urizar NL, Liverman AB, Dodds DT, Silva FV, Ordentlich P, Yan Y, Gonzalez FJ, Heyman RA, Mangelsdorf DJ, Moore DD (2002) A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296(5573):1703–1706. https://doi.org/10.1126/science.1072891
Wang YD, Chen WD, Moore DD, Huang W (2008) FXR: a metabolic regulator and cell protector. Cell Res 18(11):1087–1095. https://doi.org/10.1038/cr.2008.289
Wright CE, Tallan HH, Lin YY, Gaull GE (1986) Taurine: biological update. Annu Rev Biochem 55:427–453. https://doi.org/10.1146/annurev.bi.55.070186.002235
Yokogoshi H, Mochizuki H, Nanami K, Hida Y, Miyachi F, Oda H (1999) Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr 129(9):1705–1712. https://doi.org/10.1093/jn/129.9.1705
Yu H, Guo Z, Shen S, Shan W (2016) Effects of taurine on gut microbiota and metabolism in mice. Amino Acids 48(7):1601–1617. https://doi.org/10.1007/s00726-016-2219-y
Acknowledgements
This study was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 19K11811).
Author information
Authors and Affiliations
Contributions
Conceptualization: MM. Methodology: MM. Formal analysis and investigation: MM, TT, KT, and AF. Writing (original draft): MM. Writing (review and editing): YS. Funding acquisition: MM. Resources: MM. Supervision: MM.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Research involving human participants and/or animals
This article does not describe any studies with human participants. All experiments were conducted in accordance with the guidelines for animal experiments of the National Fisheries University (Shimonoseki, Japan). The protocol was approved by the Institutional Animal Care and Use Committee at the National Fisheries University (Permission No. 2019-18-3).
Additional information
Handling editor: Stefan Broer.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Miyata, M., Tanaka, T., Takahashi, K. et al. Cholesterol-lowering effects of taurine through the reduction of ileal FXR signaling due to the alteration of ileal bile acid composition. Amino Acids 53, 1523–1532 (2021). https://doi.org/10.1007/s00726-021-03068-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-021-03068-7